glp 1 used for Glucagon-like peptide-1 GLP-1 | Summary
Description
Robust improvement in glycaemic control (HbA1c) in people with type 2 diabetes, with dose-dependent reductions observed in clinical trials
Your PlexusDx care team can help you establish a consistent injection schedule and recommend tracking tools to ensure you never miss a dose
Have severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems with digesting food
Abstract Background Glucagonlike peptide1 receptor agonists (GLP1RAs) are an established treatment for patients with type 2 diabetes (T2D)
Ren, L., Chen, L., Qi, H., Li, F., & Gong, F
Up Next: Sources: Pandey A., Ye, Yang, Wells, C.R., et al
